Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Jerome Barakos

Showing results (1-10 of 25) with videos related to

Pageof 3
Sort By:
Alcoholism, Clinical and Experimental Research|October 29, 2009
Age-related gray matter shrinkage in a treatment naïve actively drinking alcohol-dependent sampleGeorge Fein, Ryan Shimotsu, Jerome Barakos
Alcoholism, Clinical and Experimental Research|August 4, 2009
Parietal gray matter volume loss is related to spatial processing deficits in long-term abstinent alcoholic menGeorge Fein, Ryan Shimotsu, Russell Chu, et al.
Alcoholism, Clinical and Experimental Research|November 4, 2008
Increased white matter signal hyperintensities in long-term abstinent alcoholics compared with nonalcoholic controlsGeorge Fein, Ryan Shimotsu, Victoria Di Sclafani, et al.
Neuroimage|July 29, 2006
Brain atrophy in long-term abstinent alcoholics who demonstrate impairment on a simulated gambling taskGeorge Fein, Bennett Landman, Hoang Tran, et al.
Neuroimage|January 29, 2013
A two-level multimodality imaging Bayesian network approach for classification of partial epilepsy: preliminary dataSusanne G Mueller, Karl Young, Miriam Hartig, et al.
Neuroimage|January 31, 2006
Statistical parametric mapping of brain morphology: sensitivity is dramatically increased by using brain-extracted images as inputsGeorge Fein, Bennett Landman, Hoang Tran, et al.
Alzheimer'S & Dementia : the Journal of the Alzheimer'S Association|July 26, 2011
Prevalence of asymptomatic vasogenic edema in pretreatment Alzheimer's disease study cohorts from phase 3 trials of semagacestat and solanezumabChristopher Carlson, Wahiba Estergard, Joonmi Oh, et al.
Epilepsia|April 30, 2009
Subfield atrophy pattern in temporal lobe epilepsy with and without mesial sclerosis detected by high-resolution MRI at 4 Tesla: preliminary resultsSusanne G Mueller, Kenneth D Laxer, Jerome Barakos, et al.
Alzheimer'S & Dementia (Amsterdam, Netherlands)|May 31, 2016
Amyloid-related imaging abnormalities from trials of solanezumab for Alzheimer's diseaseChristopher Carlson, Eric Siemers, Ann Hake, et al.
Psychiatry Research|August 18, 2004
Controlling for premorbid brain size in imaging studies: T1-derived cranium scaling factor vs. T2-derived intracranial vault volumeGeorge Fein, Victoria Di Sclafani, Colin Taylor, et al.
Pageof 3

Showing results (1-10 of 25) with videos related to

Sort By:
Pageof 3
Alcoholism, Clinical and Experimental Research|October 29, 2009
Age-related gray matter shrinkage in a treatment naïve actively drinking alcohol-dependent sampleGeorge Fein, Ryan Shimotsu, Jerome Barakos
Alcoholism, Clinical and Experimental Research|August 4, 2009
Parietal gray matter volume loss is related to spatial processing deficits in long-term abstinent alcoholic menGeorge Fein, Ryan Shimotsu, Russell Chu, et al.
Alcoholism, Clinical and Experimental Research|November 4, 2008
Increased white matter signal hyperintensities in long-term abstinent alcoholics compared with nonalcoholic controlsGeorge Fein, Ryan Shimotsu, Victoria Di Sclafani, et al.
Neuroimage|July 29, 2006
Brain atrophy in long-term abstinent alcoholics who demonstrate impairment on a simulated gambling taskGeorge Fein, Bennett Landman, Hoang Tran, et al.
Neuroimage|January 29, 2013
A two-level multimodality imaging Bayesian network approach for classification of partial epilepsy: preliminary dataSusanne G Mueller, Karl Young, Miriam Hartig, et al.
Neuroimage|January 31, 2006
Statistical parametric mapping of brain morphology: sensitivity is dramatically increased by using brain-extracted images as inputsGeorge Fein, Bennett Landman, Hoang Tran, et al.
Alzheimer'S & Dementia : the Journal of the Alzheimer'S Association|July 26, 2011
Prevalence of asymptomatic vasogenic edema in pretreatment Alzheimer's disease study cohorts from phase 3 trials of semagacestat and solanezumabChristopher Carlson, Wahiba Estergard, Joonmi Oh, et al.
Epilepsia|April 30, 2009
Subfield atrophy pattern in temporal lobe epilepsy with and without mesial sclerosis detected by high-resolution MRI at 4 Tesla: preliminary resultsSusanne G Mueller, Kenneth D Laxer, Jerome Barakos, et al.
Alzheimer'S & Dementia (Amsterdam, Netherlands)|May 31, 2016
Amyloid-related imaging abnormalities from trials of solanezumab for Alzheimer's diseaseChristopher Carlson, Eric Siemers, Ann Hake, et al.
Psychiatry Research|August 18, 2004
Controlling for premorbid brain size in imaging studies: T1-derived cranium scaling factor vs. T2-derived intracranial vault volumeGeorge Fein, Victoria Di Sclafani, Colin Taylor, et al.
Pageof 3